<DOC>
	<DOC>NCT01447797</DOC>
	<brief_summary>The purpose of this study is to evaluate pharmacokinetics and safety after oral administration of Irbesartan and Atorvastatin in combination as HCP0912</brief_summary>
	<brief_title>A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Irbesartan</mesh_term>
	<criteria>Age between 20 and 45 Signed informed consent form weight : over 45kg and in the range of Â±20% of IBW Has a medical history of hypersensitivity to atorvastatin or irbesartan severe Hypotension Not eligible for subject in health examination within 28 days of IP administration</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Irbesartan</keyword>
	<keyword>Atorvastatin</keyword>
	<keyword>combination</keyword>
</DOC>